1. United States Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: other
Medican Enterprises Inc

Medican Enterprises Inc

OOTC:MDCN
0.00
USD
0.00
(0.00%)
-17.92EPS
9.91MMarket Cap
Medican Enterprises Inc
OTC:MDCN
(OTC Markets)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
TTM
USD
0.07
1.43
1.03
0.53
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Revenue per Share
-0.02
-0.25
- -
-0.67
0.03
-0.01
- -
- -
-0.01
- -
- -
- -
-0.01
-0.14
-11.59
-17.92
Basic EPS, GAAP
-0.02
-0.3
0.05
0.02
- -
- -
- -
- -
- -
- -
- -
- -
- -
-0.01
-0.61
-0.4
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-0.57
-0.79
-0.8
-2.6
- -
-0.09
-0.01
-0.02
-0.02
-0.03
-0.03
-0.03
-0.04
-0.11
-1.7
-2.42
Book Value per Share
-0.57
-0.79
-0.8
-2.6
- -
-0.09
-0.01
-0.02
-0.02
-0.03
-0.03
-0.03
-0.04
-0.11
-1.7
-2.42
Tangible Book Value per Share
7
- -
- -
- -
7
3
3
3
3
3
3
3
3
3
5
8
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
-28.36
-15.29
8.08
-7.84
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-57
-135
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-28.04
-17.24
0.12
-125.54
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
-1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-8
-10
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
- -
- -
- -
-1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-8
-114
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
-18
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

USD

•

in mil. unless spec.
Sep'14
Dec'14
Mar'15
ST Debt
- -
6
8
LT Borrowings
1
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
5
5
47
Market Capitalization
19
1
10

Working Capital

USD

•

in mil. unless spec.
Sep'14
Dec'14
Mar'15
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
8
10
Payables & Accruals
- -
2
2
ST Debt
- -
6
8
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
9.5%
586.13%
2,696.62%
Free Cash Flow
- -
- -
14,752.28%
Net Income, GAAP
1,681.92%
3,391.82%
14,914.37%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2013
- -
- -
- -
- -
- -
2014
- -
- -
- -
- -
- -
2015
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2013
- -
-0.01
-0.01
-0.12
-0.14
2014
-10.43
-2.1
-1.87
-1.82
-11.59
2015
-6.58
- -
- -
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2013
- -
- -
- -
- -
- -
2014
- -
- -
- -
- -
- -
2015
- -
- -
- -
- -
- -
Similar Companies
Cipla Ltd (NSE:CIPLA)
Aurobindo Pharma Ltd (NSE:AUROPHARMA)
Lupin Limited (NSE:LUPIN)
Granules India Limited (NSE:GRANULES)
Revolution Medicines, Inc. (NASDAQ:RVMD)
Egyptian International Pharmaceutical Industries Co. (EGX:PHAR)
Business
Medican Enterprises, Inc. (MDCN) is a holding company focused on investments across real estate, sports, entertainment, and bio-pharmaceutical sectors with historical roots in cannabis-related activities. Founded in 1988 and headquartered in Las Vegas, Nevada, the company engages in residential and commercial real estate investment and development, including multifamily housing, retail spaces, office buildings, mixed-use developments, and adaptive reuse projects primarily in California, Nevada, Atlanta, and other U.S. metropolitan areas; it also pursues opportunities in medical and recreational marijuana production, cultivation, wholesale distribution, research, marketing, training, and retail sales through joint ventures and subsidiaries like Medican Systems Inc. in the United States and Canada, alongside stakes in basketball franchises, digital media assets, and pharmaceutical-grade cannabis strains such as high THC/low CBD, medium THC/medium CBD, and low THC/high CBD varieties. Recent developments include the acquisition of a majority stake in Vivian Legacy LLC and expansion into skincare products; a new majority shareholder announcement; stakes in real estate firms like Equity Apple Inc. and 49% in R & B Property Development Limited in 2021 and 2024; a 2019 merger agreement with Immediate Properties LLC shifting emphasis to real estate while retaining a $10 convertible note in The Now Corporation for hemp and THC medicinal applications; and leadership changes with Kelvin Lindsey as CEO and Kris Klassen as President.

Company News

Company News APIChatGPT

  • defenseworld.net

    Medican Enterprises (OTCMKTS:MDCN) Share Price Crosses Above 50-Day Moving Average – Here’s What Happened